Personalized Medicine and the Impact on the Pharmaceutical Company

Sanjiv S. Agarwala, MD

Video Categories: Personalized Medicine

Dr Agarwala hypothesizes how the future of the traditional pharmaceutical company may change with the developments in personalized medicine.
November 19, 2014

Payer Coverage in Polycythemia Vera

Ken Schaecher, MD, Medical Director of SelectHealth, describes in his opinion how there is no payer coverage issues with patients with polycythemia vera at this time. Supported through funding from Incyte

July 13, 2021

Real-World Experience with TRK Inhibitors in Patients with Lung and Colon Cancers

Dr Mary Fidler of Rush University Medical Center, Chicago, IL, and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, describe their practical experiences with TRK inhibitors in patients with lung cancer and colorectal cancer.